Interferon regulatory factors: critical mediators of human lupus.

[1]  O. Nureki,et al.  Cyclic GMP-AMP as an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA. , 2017, Annual review of biochemistry.

[2]  Hongliang Li,et al.  Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease. , 2015, Biochimica et biophysica acta.

[3]  C. Jefferies,et al.  IRF5-mediated signaling and implications for SLE. , 2014, Clinical immunology.

[4]  C. Jefferies,et al.  TRIpartite Motif 21 (TRIM21) Differentially Regulates the Stability of Interferon Regulatory Factor 5 (IRF5) Isoforms , 2014, PloS one.

[5]  R. Bonegio,et al.  Interferon Regulatory Factor-5 Deficiency Ameliorates Disease Severity in the MRL/lpr Mouse Model of Lupus in the Absence of a Mutation in DOCK2 , 2014, PloS one.

[6]  T. Noda,et al.  Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. , 2014, Immunity.

[7]  K. Honda,et al.  MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells. , 2014, Molecular immunology.

[8]  Adriano G. Rossi,et al.  Apoptotic cell clearance: basic biology and therapeutic potential , 2014, Nature Reviews Immunology.

[9]  L. Ivashkiv,et al.  Regulation of type I interferon responses , 2013, Nature Reviews Immunology.

[10]  T. Niewold,et al.  Genetics of the type I interferon pathway in systemic lupus erythematosus. , 2013, International journal of clinical rheumatology.

[11]  T. Niewold,et al.  Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus , 2013, Front. Immunol..

[12]  J. Harley,et al.  Familial Aggregation of High Tumor Necrosis Factor Alpha Levels in Systemic Lupus Erythematosus , 2013, Clinical & developmental immunology.

[13]  Eugenia G. Giannopoulou,et al.  Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling. , 2013, Immunity.

[14]  S. O’Neill,et al.  Clinical aspects of autoimmune rheumatic diseases , 2013, The Lancet.

[15]  A. Reder,et al.  Genetic Variation near IRF8 is Associated with Serologic and Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis , 2013, Genes and Immunity.

[16]  A. Reder,et al.  Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology , 2013, Front. Immunol..

[17]  T. Beddoe,et al.  Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1 , 2013, Nature Immunology.

[18]  D. Monack,et al.  Newly described pattern recognition receptors team up against intracellular pathogens , 2013, Nature Reviews Immunology.

[19]  C. Reis e Sousa,et al.  Cytosolic Sensing of Viruses , 2013, Immunity.

[20]  A. Bowie,et al.  Immune sensing of DNA. , 2013, Immunity.

[21]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.

[22]  K. Ishii,et al.  DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking , 2013, Proceedings of the National Academy of Sciences.

[23]  Scott M. Williams,et al.  Admixture Mapping in Lupus Identifies Multiple Functional Variants within IFIH1 Associated with Apoptosis, Inflammation, and Autoantibody Production , 2013, PLoS genetics.

[24]  Larissa B. Thackray,et al.  IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS Signaling , 2013, PLoS pathogens.

[25]  T. Niewold,et al.  Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus , 2012, Clinical & developmental immunology.

[26]  P. Gaffney,et al.  Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[27]  J. Buyon,et al.  Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus. , 2012, Arthritis and rheumatism.

[28]  A. Reder,et al.  Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins. , 2012, Archives of neurology.

[29]  N. DeLuca,et al.  Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein , 2012, Proceedings of the National Academy of Sciences.

[30]  J. Harley,et al.  Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[31]  R. Cantor,et al.  Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups , 2012, Annals of the rheumatic diseases.

[32]  A. Skol,et al.  Gene-Expression-Guided Selection of Candidate Loci and Molecular Phenotype Analyses Enhance Genetic Discovery in Systemic Lupus Erythematosus , 2012, Clinical & developmental immunology.

[33]  R. Maul,et al.  Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response , 2012, Genes and Immunity.

[34]  J. Darnell,et al.  The JAK-STAT pathway at twenty. , 2012, Immunity.

[35]  P. Gaffney,et al.  Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. , 2012, American journal of human genetics.

[36]  A. Reder,et al.  Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis , 2012, Journal of the Neurological Sciences.

[37]  D. Stetson,et al.  Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. , 2012, Immunity.

[38]  M. Jolly,et al.  The Autoimmune Disease Risk Allele of UBE2L3 in African American Patients with Systemic Lupus Erythematosus: A Recessive Effect Upon Subphenotypes , 2012, The Journal of Rheumatology.

[39]  T. Niewold.  Interferon alpha as a primary pathogenic factor in human lupus. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[40]  P. Gaffney,et al.  IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus , 2011, Annals of the rheumatic diseases.

[41]  Yong‐jun Liu,et al.  The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells , 2011, Nature Immunology.

[42]  G. Barber,et al.  IRF7: activation, regulation, modification and function , 2011, Genes and Immunity.

[43]  G. McFadden,et al.  Myxoma Virus Induces Type I Interferon Production in Murine Plasmacytoid Dendritic Cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-Dependent Pathway , 2011, Journal of Virology.

[44]  M. Jolly,et al.  Autoimmune Disease Risk Variant of IFIH1 Is Associated with Increased Sensitivity to IFN-α and Serologic Autoimmunity in Lupus Patients , 2011, The Journal of Immunology.

[45]  Damien Chaussabel,et al.  IRF8 mutations and human dendritic-cell immunodeficiency. , 2011, The New England journal of medicine.

[46]  T. Niewold,et al.  Interferon regulatory factors in human lupus pathogenesis. , 2011, Translational research : the journal of laboratory and clinical medicine.

[47]  C D Langefeld,et al.  Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort , 2011, Genes and Immunity.

[48]  J. Harley,et al.  Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[49]  Annette Lee,et al.  Differential Genetic Associations for Systemic Lupus Erythematosus Based on Anti–dsDNA Autoantibody Production , 2011, PLoS genetics.

[50]  H. Lockstone,et al.  IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses , 2011, Nature Immunology.

[51]  P. Gregersen,et al.  Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus , 2011, Nature Genetics.

[52]  F. Arnett,et al.  Association of a functional IRF7 variant with systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[53]  Cheng-de Yang,et al.  Anti-class a scavenger receptor autoantibodies from systemic lupus erythematosus patients impair phagocytic clearance of apoptotic cells by macrophages in vitro , 2011, Arthritis research & therapy.

[54]  M. Si-Tahar,et al.  A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients , 2011, EMBO Molecular Medicine.

[55]  A. Bowie,et al.  IFI16 is an innate immune sensor for intracellular DNA , 2010, Nature Immunology.

[56]  A. Skol,et al.  Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus , 2010, Arthritis research & therapy.

[57]  Timothy B. Niewold,et al.  Interferon Alpha in Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.

[58]  B. Beutler,et al.  Intracellular toll-like receptors. , 2010, Immunity.

[59]  D. Huso,et al.  Critical role of IRF-5 in regulation of B-cell differentiation , 2010, Proceedings of the National Academy of Sciences.

[60]  T. Niewold,et al.  Genetic regulation of serum cytokines in systemic lupus erythematosus. , 2010, Translational research : the journal of laboratory and clinical medicine.

[61]  M. Jolly,et al.  Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. , 2010, Arthritis and rheumatism.

[62]  Gerald McGwin,et al.  A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus , 2009, Nature Genetics.

[63]  M. Ferrari,et al.  TREX1 gene variant in neuropsychiatric systemic lupus erythematosus , 2009, Annals of the rheumatic diseases.

[64]  G. Barber,et al.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity , 2009, Nature.

[65]  A. Syvänen,et al.  A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus , 2009, Annals of the rheumatic diseases.

[66]  Zhijian J. Chen,et al.  RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway , 2009, Cell.

[67]  Osamu Takeuchi,et al.  Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. , 2009, Immunity.

[68]  Ludwig Kappos,et al.  Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.

[69]  P. Gaffney,et al.  Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. , 2009, Arthritis and rheumatism.

[70]  Don L. Armstrong,et al.  High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. , 2009, Arthritis and rheumatism.

[71]  G. Superti-Furga,et al.  An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome , 2009, Nature Immunology.

[72]  Jasmyn A. Dunn,et al.  HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA , 2009, Science.

[73]  B. Roep.  Faculty Opinions recommendation of Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. , 2009 .

[74]  Daniel R. Caffrey,et al.  AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC , 2009, Nature.

[75]  T. Niewold,et al.  Cutting Edge: Autoimmune Disease Risk Variant of STAT4 Confers Increased Sensitivity to IFN-α in Lupus Patients In Vivo1 , 2009, The Journal of Immunology.

[76]  C. Schiffer,et al.  Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5 , 2008, Nature Structural &Molecular Biology.

[77]  David Altshuler,et al.  Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus , 2008, Nature Genetics.

[78]  T. Niewold,et al.  The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus. , 2008, Arthritis and rheumatism.

[79]  T. Heidmann,et al.  Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity , 2008, Cell.

[80]  J. Harley,et al.  Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. , 2008, Arthritis and rheumatism.

[81]  S. Akira,et al.  Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5 , 2008, The Journal of experimental medicine.

[82]  J. Harley,et al.  Age- and sex-related patterns of serum interferon-alpha activity in lupus families. , 2008, Arthritis and rheumatism.

[83]  Carey L. Medin,et al.  Functional Characterization of Murine Interferon Regulatory Factor 5 (IRF-5) and Its Role in the Innate Antiviral Response* , 2008, Journal of Biological Chemistry.

[84]  K. Rock,et al.  How dying cells alert the immune system to danger , 2008, Nature Reviews Immunology.

[85]  T. Taniguchi,et al.  The IRF family transcription factors in immunity and oncogenesis. , 2008, Annual review of immunology.

[86]  L. Milani,et al.  Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. , 2008, Human molecular genetics.

[87]  E. Latz,et al.  The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation. , 2008, Immunity.

[88]  Shizhong Han,et al.  Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus , 2008, PloS one.

[89]  T. Taniguchi,et al.  A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis , 2008, Proceedings of the National Academy of Sciences.

[90]  J. Buyon,et al.  Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. , 2008, Arthritis and rheumatism.

[91]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[92]  A. Scheynius,et al.  Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus , 2007, The Journal of experimental medicine.

[93]  J. Lieberman,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus , 2007, Nature Genetics.

[94]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[95]  J. Lieberman,et al.  A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus , 2007, Journal of Molecular Medicine.

[96]  Geoffrey Hom,et al.  Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus , 2007, Proceedings of the National Academy of Sciences.

[97]  S. Akira,et al.  Cutting Edge: Role of TANK-Binding Kinase 1 and Inducible IκB Kinase in IFN Responses against Viruses in Innate Immune Cells1 , 2006, The Journal of Immunology.

[98]  K. Honda,et al.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors , 2006, Nature Reviews Immunology.

[99]  D. Barnes,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus , 2006, Nature Genetics.

[100]  M. Crow,et al.  Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. , 2006, Arthritis and rheumatism.

[101]  S. Akira,et al.  "Endogenous adjuvant" activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60. , 2006, Arthritis and rheumatism.

[102]  Marta E Alarcón-Riquelme,et al.  A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus , 2006, Nature Genetics.

[103]  Stefan Bauer,et al.  CpG motif‐independent activation of TLR9 upon endosomal translocation of “natural” phosphodiester DNA , 2006, European journal of immunology.

[104]  S. Akira,et al.  Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus , 2005, The Journal of experimental medicine.

[105]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[106]  Katherine E. M. Hoops,et al.  Two Discrete Promoters Regulate the Alternatively Spliced Human Interferon Regulatory Factor-5 Isoforms , 2005, Journal of Biological Chemistry.

[107]  Stefan Bauer,et al.  Endosomal Translocation of Vertebrate DNA Activates Dendritic Cells via TLR9-Dependent and -Independent Pathways 1 , 2005, The Journal of Immunology.

[108]  D. Golenbock,et al.  The Interferon Regulatory Factor, IRF5, Is a Central Mediator of Toll-like Receptor 7 Signaling* , 2005, Journal of Biological Chemistry.

[109]  Hideo Negishi,et al.  IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.

[110]  T. Niewold,et al.  Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C , 2005, Clinical Rheumatology.

[111]  C. Coban,et al.  Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction , 2005, The Journal of experimental medicine.

[112]  Tak W. Mak,et al.  Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors , 2005, Nature.

[113]  J. Kere,et al.  Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. , 2005, American journal of human genetics.

[114]  D. Golenbock,et al.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. , 2005, The Journal of clinical investigation.

[115]  M. Peterson,et al.  Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus , 2004 .

[116]  S. Hanash,et al.  Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral Infection* , 2004, Journal of Biological Chemistry.

[117]  Kristin G Ardlie,et al.  Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. , 2004, American journal of human genetics.

[118]  L. Rönnblom,et al.  Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. , 2004, Arthritis and rheumatism.

[119]  K. Ishii,et al.  Toll-Like Receptor 9 Signaling Activates NF-κB through IFN Regulatory Factor-8/IFN Consensus Sequence Binding Protein in Dendritic Cells1 , 2004, The Journal of Immunology.

[120]  Virginia Pascual,et al.  Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.

[121]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[122]  P. Pitha,et al.  Multiple Regulatory Domains of IRF-5 Control Activation, Cellular Localization, and Induction of Chemokines That Mediate Recruitment of T Lymphocytes , 2002, Molecular and Cellular Biology.

[123]  T. Taniguchi,et al.  Gene induction pathways mediated by distinct IRFs during viral infection. , 2001, Biochemical and biophysical research communications.

[124]  J. Hiscott,et al.  Multiple Regulatory Domains Control IRF-7 Activity in Response to Virus Infection* , 2000, The Journal of Biological Chemistry.

[125]  T. Taniguchi,et al.  Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in Response to Viruses for IFN-α/β Gene Induction , 2000 .

[126]  T. Taniguchi,et al.  Crystal structure of an IRF‐DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences , 1999, The EMBO journal.

[127]  J. Hiscott,et al.  Structural and Functional Analysis of Interferon Regulatory Factor 3: Localization of the Transactivation and Autoinhibitory Domains , 1999, Molecular and Cellular Biology.

[128]  D. Mevorach,et al.  Complement-dependent Clearance of Apoptotic Cells by Human Macrophages , 1998, The Journal of experimental medicine.

[129]  T. Taniguchi,et al.  Positive feedback regulation of type I IFN genes by the IFN‐inducible transcription factor IRF‐7 , 1998, FEBS letters.

[130]  D. Levy,et al.  Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7 , 1998, The EMBO journal.

[131]  Pier Paolo Pandolfi,et al.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies , 1998, Nature Genetics.

[132]  M. Herrmann,et al.  High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus , 1998, Lupus.

[133]  A. Aggarwal,et al.  Structure of IRF-1 with bound DNA reveals determinants of interferon regulation , 1998, Nature.

[134]  T. Taniguchi,et al.  IRF-1: the transcription factor linking the interferon response and oncogenesis. , 1997, Biochimica et biophysica acta.

[135]  J. Ahearn,et al.  C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. , 1997, Journal of immunology.

[136]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[137]  L. Rönnblom,et al.  Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumour , 1990, Journal of internal medicine.

[138]  A. Notkins,et al.  Immune interferon in the circulation of patients with autoimmune disease. , 1979, The New England journal of medicine.

[139]  G. Edelman,et al.  Properties of Deoxyribonuclease III from Mammalian Tissues , 1969 .

[140]  J. Harley,et al.  Large Scale Analysis of Tumor Necrosis Factor Alpha Levels in Systemic Lupus Erythematosus , 2012 .

[141]  J. Harley,et al.  High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. , 2007, Genes and immunity.

[142]  Zhijian J. Chen,et al.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. , 2005, Cell.

[143]  M. Peterson,et al.  Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[144]  I. Baumann,et al.  Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[145]  T. Taniguchi,et al.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. , 2000, Immunity.

[146]  Ohira,et al.  Crystallographic Characterization of the DNA-Binding Domain of Interferon Regulatory Factor-2 Complexed with DNA. , 1998, Journal of structural biology.

[147]  G. Edelman,et al.  Properties of deoxyribonuclease 3 from mammalian tissues. , 1969, The Journal of biological chemistry.

[148]  The AIM2 inflammasome is critical for innate immunity to , 2022 .